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Imaging Sciences Retreat 
Pathways to Discovery 
In the future, solving complex biomedical problems may be determined 
by how well the next generation of imaging scientists is trained in basic 
biological issues and technical know-how.   Washington University's innovative 
curriculum—called Imaging Sciences Pathway (ISPj—offers a unique learning 
experience for undergraduate and graduate students from several disciplines. 
In April 2008, the Imaging Sciences Retreat 
highlighted the ISP as well as the students who     _ 
are enrolled in this challenging program. 
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Photography by Mickey Wynn, MIR Photography lab 
Top, left: Keynote Speaker Robert Balaban, PhD, 
of the National Heart Lung and Blood Institute's 
Laboratory of Cardiac Energetics, spoke on 
"In vivo sub-cellular imaging using non-linear 
optical microscopy." 
Top, right: Kari Alca coordinated the registration for 
the Retreat, which was held at the Hyatt Regency 
St. Louis Riverfront. 
Right: Carolyn Anderson, PhD, professor of radiology 
and codirector of ISP, presented an update of the 
Imaging Sciences Pathway initiative. 
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5 The Center for 
Clinical Imaging Research 
After five years in the making, the 
CCIR—a comprehensive imaging 
center dedicated to innovative 
research—hosted an open house in 
February of this year. 
8 Radiotherapy for Graves' Disease 
A nuclear medicine specialist dis- 
cusses the safety and effectiveness 
of using radiotherapy to manage 
Graves' disease, the most common 
cause of hyperthyroidism. 
13 Resolving the Mysteries of Autism 
A five-year national study involving 
siblings of children diagnosed with 
autism uses magnetic resonance 
imaging to investigate structural 
and functional neural development. 
1 8 The National Oncologic 
PET Registry 
The results of a nationwide effort 
to measure the effect that findings 
of PET scans have on cancer treat- 
ment decisions may lead to changes 
in the Center for Medicare and 
Medicaid Services coverage policy. 
■ On Duty in Iraq 
A Mallinckrodt Institute physician 
shares his experiences as the only 
radiologist on duty at the 325th 
Combat Support Hospital, the pri- 
mary United States military health- 
care facility in Al Anbar province. 
ON THE COVER Magnetic resonance imaging-based 
research involving volunteers like this little girl may 
provide new insights into diagnosing autism in very 
young children.   Courtesy photo. 
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WUSM moves up a notch 
In the 2008 U.S. News & World Report rankings, 
Washington University in St. Louis School of Medicine 
(WUSM) moved from its 2007 fourth-place spot and is 
now positioned third in overall rankings among 
research-oriented medical schools. WUSM continues 
to hold first place in student selectivity, based on 
college grade-point averages and MCAT scores. Other 
medical schools listed in the top five are Harvard 
University (ranked first); Johns Hopkins University 
(second); University of Pennsylvania (fourth); and 
University of California, San Francisco (fifth). 
SCC earns excellence award 
The American College of Radiology (ACR) has 
designated the Joanne Knight Breast Health Center at 
Siteman Cancer Center (SCC) as a Breast Imaging Center 
of Excellence. The Center of Excellence award recog- 
nizes the SCC for earning accreditation in all of the 
ACR's voluntary breast-imaging accreditation programs 
and modules as well as the mandatory Mammography 
Accreditation Program. The SCC's breast imaging 
services are fully accredited in mammography, 
stereotactic breast biopsy, breast ultrasound, and 
ultrasound-guided breast biopsy. 
Middleton named Teacher 
of the Year 
Radiology senior residents annually present the 
Diagnostic Radiology Teacher of the Year award to a 
faculty member who has made outstanding contributions 
to resident education. William Middleton, MD, professor 
of radiology—and the 2007-2008 honoree—is a two- 
time recipient. 
PAST RECIPIENTS 
David Ling, MD 1985 
Fernando Gutierrez, MD 1986 
Dennis Balfe, MD 1983 and 1987 
Stuart Sagel, MD 1988 
Marilyn Siegel, MD 1984 and 1989 
Barry Siegel, MD 1990 
Franz Wippold, MD 1991 
Anthony Wilson, MD 1992 
William Middleton, MD 1993 
Jay Heiken, MD 1994 
Gary Shackelford, MD 1995 
Mokhtar Gado, MD 1996 
Premsri Barton, MD 1997 
Harvey Glazer, MD 1998 
William Totty, MD 1999 
Thomas Herman, MD 2000 
Barbara Monsees, MD 2001 
William McAlister, MD 2002 
Sanjeev Bhalla, MD 2003 
Christine Menias, MD 2004 
Katie Vo, MD 2005 
Vamsi Narra, MD 2006 
Robert McKinstry, MD, PhD 2007 
Middleton is shown with Sara Rohr, MD, 2007-2008 diagnostic 
radiology chief resident. 
MALLINCKRODTINSTITUTE OFRADIOLOGl 
Matching Program results 
announced 
In July, 18 physicians will begin their first year of 
training in diagnostic radiology at Mallinckrodt 
Institute. The 2008-2009 trainees come from the 
following schools: 
• Albert Einstein College of Medicine, 
Yeshiva University (1) 
• Duke University School of Medicine (2) 
• Kazan State Medical University (1) 
• Mount Sinai School of Medicine of New York 
University (1) 
• New York Medical College (1) 
• Pontificia Universidad Catolica de Chile (1) 
• Pritzker School of Medicine, University of Chicago (1) 
• Saint Louis University School of Medicine (1) 
• Southern Illinois University School of Medicine (1) 
• University of California Los Angeles David Geffen 
School of Medicine (1) 
• University of Louisville School of Medicine (1) 
• University of Miami School of Medicine (1) 
• University of Texas Medical School at Houston (2) 
• Washington University in St. Louis School of 
Medicine (3) 
I Wilson Award in its 40th year 
The 2008 Hugh M. Wilson Award for Meritorious 
Work in Radiology was presented on May 16, at the 
senior program following Washington University's 147th 
Commencement ceremony, to two outstanding recipients: 
Michael Fox, and Mai-Lan Ho. Fox, an MD/PhD student, 
completed his doctoral research in the Neuroimaging 
Lab with Marcus Raichle, MD, professor of radiology, of 
neurology, of neurobiology, and of psychology. Ho, a 
fourth-year medical student, worked in the Abdominal 
Radiology section under the mentorship of Vamsi Narra, 
MD, associate professor of radiology. The annual Wilson 
Award honors Mallinckrodt Institute's second director, 
an advocate of the advancement of education. 
Gilbert Jost, MD, head of the Department of Radiology and director of Mallinckrodt 
Institute, was one of three physicians named as honorary members of the Euro- 
pean Society of Radiology ot the Society's annual meeting in Vienna. Honorees: 
(left to right) Jost; Lizbetfi Kenny, MD, director of Cancer Services for the Central 
Area Health Service, Royal Brisbane (Australia) and Women's Hospital; and 
Frederick Keller, MD, chair of the Department of Radiology and director of the 
Dotter Interventional Institute of the Oregon Health and Science University. 
Haven joins the 
Institute 
Joy Haven, PhD, newly 
appointed executive officer for 
business operations, comes to 
Mallinckrodt Institute from the 
Washington University School of 
Medicine (WUSM) Cardiovascular 
Division, where she served as 
executive officer for six years. 
Prior to her WUSM experience, 
she held leadership positions in the 
medical insurance field. Haven 
graduated summa cum laude from 
Washington University with a dou- 
ble major in economics and psychology. She also 
earned an MBA and a doctoral degree in clinical 
psychology at the University. 
Haven's appointment was announced as Linda 
Davidson, executive director of business affairs and an 
MIR employee for 21 years, transitions to retirement. 




University School of Med- 
icine (WUSM) Alumni 
Association Executive 
Committee named one 
of the four WUSM Distin- 
guished Professor 2008 
scholarships in honor 
of Emily Smith, MD, 
assistant professor of 
radiology. The four-year, 
full-tuition, merit-based 
scholarships are awarded 
annually to first-year 
medical students. 
Vamsi Narra, MD, 
associate professor of 
radiology, was named 
chief of radiology at 
Barnes-Jewish West 
County Hospital. Narra 
also is chief of clinical 
operations at the West 
County Hospital, where 
enhanced radiology ser- 
vices are an integral part 
of Washington University 
School of Medicine's 
expanded operations. 
Benzinger receives dual awards 
Tammie Benzinger, MD, PhD, 
assistant professor of radiology, 
may be the only honoree to have 
been named an ARRS Scholar and 
an ASNR/NER Foundation Scholar 
in the same year. Benzinger, a 
neuroradiologist, received both awards 
based on her research involving 
magnetic resonance imaging (MRI). 
The two-year American Roent- 
gen Ray Society (ARRS) /Bracco 
Diagnostics award of $140,000 will 
fund the use of MRI to better 
understand the microstructural 
environment of the central nervous 
system—a collaborative study 
between Mallinckrodt Institute's 
Center for Clinical Imaging 
Research (CCIR) and the Beckman 
Institute at the University of Illinois at Urbana-Champaign (UIUC). Benzinger's mentors 
for this project are Victor Song, PhD, associate professor of radiology; Mark Mintun, 
MD, professor of radiology and of psychiatry, and director of the CCIR; and Zhi-Pei 
Liang, PhD, at UIUC. The focus of the $60,000 American Society for Neuroradiology 
(ASNR)/National Education and Research (NER) Foundation scholarship is the applica- 
tion of MRI directional diffusivity as a tool for prognosis and response to therapy in 
childhood leukodystrophy with neuromuscular disability. 
\ 
Becky Salmo, manager, information systems, was a member of a delegation of 
healthcare information and management system professionals that travelled to 
India, an emerging leader in the field of health information technology. During 
the eight-day visit, the delegation—sponsored by People to People Citizen 
Ambassador Programs and in partnership with the Healthcare Information 
and Management Systems Society (HIMSS)—met with representatives 
of various healthcare groups, including New Delhi's Maulana Azad Medical 
College (one of India's premier medical schools) and its five associated 
hospitals, and Indraprastha Apollo, the largest hospital in the Apollo Hospitals 
Group, the largest integrated healthcare company in India; and Fortis 
Healthcare Ltd, the leading healthcare provider in North India. Salmo (left) 
is shown receiving a plaque from a representative of Fortis Healthcare Ltd, 
citing the HIMSS visit to create global synergies in the development of 
healthcare technology. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 






Mark Mintun, MD, professor of radiology and director of Mailinckrodt Insti- 
tute's Center for Clinical Imaging Research (CCIR), is understandably proud of 
this multimillion-dollar facility that provides an enormous opportunity for advancing 
medical science and improving clinical care. From the first planning discussions in 
2003 to the installation of the most advanced, FDA-improved imaging technology in 
2007, the CCIR has been eagerly anticipated by the Washington University School 
of Medicine (WUSM) research community. With the February 28th Open 
House, the facility was officially presented to Mailinckrodt Institute faculty and staff, 
WUSM clinicians and researchers, and industry collaborators. 
Photography by Kimberly Kania, MIR Photography Lab 




(Left to right) Doctors Lorry Shapiro, executive 
chancellor (or medical affairs and dean of the 
School of Medicine; Gilbert Jost, head of the 
Department of Radiology and director of 
Mallinckrodt Institute; Mark Mintun; and Mark 
Wrighton, chancellor of Washington Univer- 
sity, presided at the ribbon-cutting ceremony 
that officially opened the CCIR. 
Above: Scott Love, RT, MRI technol- 
ogist, discusses magnetic resonance 
imaging with Washington University 
Chancellor Mark Wrighton. 
Left: Magnetic resonance imaging 
scanner (MRI), one of two 
high-powered units in the CCIR   - 
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Right: (Second from left) John Kotyk, PhD, 
CCIR associate director, led a tour of the 
positron emission tomography/computed 
tomography (PET/CT) area. 
Below: CT Supervisor Tim Street (third 
from right) answers questions about the 
64-slice CT scanner. 
The CCIR staff: (left to right) Betsy Thomas, RN, 
CCRC, clinical research specialist and protocol 
developer; Mark Nolte, RT, MRI technologist; Linda 
Becker, CNMT, PET technologist; Michael Harrod, 
CNMT, PET technologist; Marion Harris, division 
administrator; Tim Street, RT(R)(CT), CT supervisor; 
Scott Love, RT, MRI technologist; Crystal Cannon- 
Henderson, medical secretary; and Dott Wallace, 
special project administrator. Not shown are Robin 
Link, administrative coordinator; Ruth Hofdener, RT, 
research patient coordinator; Glenn Foster, RT, MRI 
supervisor; Christopher Allen, RT, ultrasound 
technologist; Matthew House, systems manager; 
Steve Baldwin, senior programmer analyst; and 
Weimin Shen, senior programmer analyst. 
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RADIOTHERAPY     FOR 
GRAVES' DISEASE 
DISPELLING THE MYTHS 
by Amy Thomas 
Major Endocrine Glands 










From the classic, 
"What your doctor 
won't tell you," to the 
pointed, "Top 20 reasons 
why I'll never have radioiodine 
therapy," Internet posts by the 
lay public often enhance com- 
mon suspicions about the use 
of radioactive agents (or radio- 
pharmaceuticals) in the treat- 
ment of Graves' disease 
(GD)—the most common 
cause of hyperthyroidism that 
affects women up to 10 times 
more often than men. 
Patients with GD often 
experience a period of vague 
complaints such as fatigue 
or weight loss before a 
diagnosis is evident. 
The initial abatement of anxiety 
upon learning the cause of 
their ailments is short-lived 
and followed by uncertainty 
regarding treatment options— 
particularly the use of radioactive 
iodine. Anxiety-provoking statements 
can burden the informed consent 
of patients with GD and cause 
undue stress for both former and 
potential recipients of radioactive 
iodine therapy. But based on expe- 
rience and clinical studies, nuclear 
medicine specialists like Bennett 
Greenspan, MD, instructor in radi- 
ology at Mallinckrodt Institute, 
agree that radiotherapy is a safe 
and effective management choice. 
to make a definitive diagnosis. The 
subtle evolution of symptoms may 
cause a patient to disregard the 
early warning signs or to attribute 
symptoms to stress and aging. 
More specific symptoms—like 
tachycardia (rapid heart rate), 
tremor (in the hands, for example), 
and brittle hair—alert the clinician 
to possible thyrotoxicosis. Classic 
signs of skin disease (especially 
thickening of the skin) and eye 
disease (most notably, the protu- 
berance of one or both eyes) can 
firmly establish the diagnosis of 
GD. Untreated, GD can result in 
serious complications, including 
cardiac rhythm disturbance and 
Hyperthyroidism in GD is due to an autoimmune 
process in which thyroid-stimulating antibodies 
bind receptors on the thyroid gland, resulting 
in an increased production of thyroid hormones 
T3 and T4. 
A closer look at the role of radioactive 
iodine in the evaluation and treatment 
of Graves' disease provides much 
needed reassurance for patients. 
THE THYROID AND ITS HORMONES 
The thyroid gland, a butterfly- 
shaped organ situated in the neck 
near the larynx and the trachea, is 
one of the largest endocrine glands 
in the human body. It produces 
hormones (T3 and T4, of which 
iodine is an essential component) 
that control metabolism, protein 
production, and sensitivity to 
other hormones. 
Because thyrotoxicosis (exces- 
sive levels of thyroid hormone) 
affects many organ systems, the 
early manifestations of GD— 
including anxiety, insomnia, 
irritability, and weight loss—are 
not specific enough for physicians 
vision loss. The course of disease 
without treatment is thyroid 
burnout and reduced function over 
an extended time. 
Hyperthyroidism in GD is due 
to an autoimmune process in which 
thyroid-stimulating antibodies bind 
receptors on the thyroid gland, 
resulting in an increased production 
of thyroid hormones T3 and T4. 
The clinical presentation is due to 
the various effects of excess thyroid 
hormone, in addition to autoim- 
mune-mediated inflammation of 
ocular and connective tissue. 
Top: Normal thyroid scan 
Middle: Graves' disease: diffuse, uniform enlargement 
of thyroid gland 
Bottom: Multinodular goiter: enlarged thyroid gland 
but irregular in uptake; nodules vary in size and levels 
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DIAGNOSTIC IMAGING 
Patients with thyrotoxicosis 
may initially be evaluated by 
ultrasound, which can detect nodules 
a doctor cannot feel during a 
patient's physical examination and 
can identify an enlarged thyroid 
gland with increased blood flow 
that is consistent with a diagnosis 
of Graves' disease. But ultrasound 
cannot show thyroid function. 
Nuclear imaging of the thyroid 
allows visualization of biologic 
processes at the cellular level and 
provides useful information about 
thyroid activity. Patients are often 
referred to a nuclear medicine 
physician for diagnosis confirmation 
and for subsequent treatment of 
GD with radiotherapy. 
Radioactive iodine uptake and 
thyroid scanning are the diagnostic 
studies most often used to determine 
Graves' disease; the isotope 1-123 is 
typically the agent of choice. In a 
thyroid uptake test, 1-123 taken 
orally is concentrated in the thyroid 
gland. A gamma camera, which 
detects and localizes emitted radia- 
tion, is used to calculate the thyroid's 
iodine uptake. Increased iodine 
uptake indicates increased de novo 
synthesis (in which simple molecules 
turn into complex molecules 
instead of being recycled) of thyroid 
hormone, which is consistent with 
a hyperactive gland. Normal values 
for 24-hour radioiodine uptake are 
between 10 percent and 30 percent, 
while uptake in patients with GD is 
typically in the range of 50 percent 
to 80 percent. 
Uptake tests are usually done 
over a two-day period, with imaging 
performed when radiotracer uptake 
is maximal (24 hours for 1-123), and 
there are precautions for patients: 
• Discontinue use of thyroid med- 
ications prior to the examination 
as these agents could reduce iodine 
Normal values for 24-hour radioiodine uptake are 
between 10 percent and 30 percent, while uptake! 
in patients with GD is typically in the range of 50' 
percent to 80 percent. 
Top: Solitary hypofunctioning nodule: one nodule, 
functioning less than normal thyroid tissue. Not rele- 
vant to Graves' disease. 
Middle: Autonomous nodule: can function to greater 
degree than remainder of thyroid gland. Acts as 
feedback mechanism to keep thyroid functioning 
normally. Commonly suppresses remainder of thyroid. 
May cause symptoms of hyperthyroidism similar to 
Graves' disease. Can be distinguished from Graves' 
disease by thyroid scan. 
Bottom: Subacute thyroiditis: produces symptoms of 
hyperthyroidism by causing injury to gland from 
inflammatory process. Thyroid "leaks" hormone, 
producing symptoms identical to Graves' disease. 
Distinguished from Graves' disease by thyroid 
uptake and thyroid scan. 
uptake to the normal range despite 
the presence of Graves' disease. 
• Do not undergo computed tomog- 
raphy (CT) screening for four to 
six weeks prior to a scheduled 
uptake test because the iodinated 
contrast agents used with CT) 
may interfere with the uptake test. 
• Do not use amiodarone, an iodine- 
rich medication, ideally for three 
to six months prior. 
• Avoid other agents, including 
cough syrups, some vitamin 
preparations, and seaweed (kelp). 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Since radioiodine uptake can 
confirm a diagnosis of GD and fur- 
ther imaging is unlikely to change 
the management of the disease, 
thyroid scanning is performed less 
often; however, it may be useful in 
differentiating Plummer's disease 
from that of GD superimposed on 
a nodular goiter. Though both 
conditions can be treated with 
radioactive iodine, the dose needed 
to treat GD is usually lower. Thyroid 
scans of patients with GD typically 
reveal a gland with smooth con- 
tours and diffusely increased 
radioiodine uptake. A prominent 
thyroid pyramidal lobe—one of the 
thyroid's four components and 
descending from the base of the 
tongue into the anterior midline of 
the neck—is also a common finding. 
No specific safety precautions are 
needed with the use of 1-123: It is 
administered at a low dose and 
does not emit beta rays, so radiation 
exposure is negligible compared to 
that of other radioisotopes. 
Following 1-131 therapy, 
patients must have follow-up 
laboratory studies throughout their 
lifetime. Most patients will develop 
hypothyroidism but, since hormone 
replacement therapy is effective 
and inexpensive, many consider 
fc^The added benefits are a shortened duration of 
symptoms and less risk of complications from 
sustained antithyroid medication use...?? 
A SAFE AND EFFECTIVE CHOICE 
Treatment with radioiodine 
(1-131) is the most commonly used 
therapy for GD in the United 
States, with efficacy at more than 
90 percent. Contrary to popular 
belief, studies of adults with GD 
who are treated with 1-131 
show no subsequent risk of 
any kind of cancer, including 
thyroid cancer or lymphoma. 
Treatment begins to take 
effect in two to three weeks, 
maximal results occur 
between three and four months, 
and the end result includes 
many patients who are 
thankful for the resolution of 
their symptoms. While antithy- 
roid medications such as 
propylthiouracil (PTU) and 
methimazole (MMI) are rea- 
sonable alternatives, they have 
a 50 percent failure rate and 
can cause rare but severe 
adverse effects, including 
suppression of white blood 
cells (agranulocytosis), liver 
toxicity, and vasculitis (blood 
vessel inflammation). Given 
these risks, clinicians and 
patients often opt to go 
directly to radioiodine therapy, 
a safe and effective choice. 
Bennett Greenspan, MD, is a past president of the 
American College of Nuclear Physicians and of the 
Missouri Radiological Society. 
hypothyroidism a more manageable 
condition and view it as a goal of 
treatment rather than an adverse 
effect. Progression of eye disease 
is a serious consideration for 
patients with severe Graves' 
ophthalmopathy who are undergoing 
radioiodine therapy, but recent 
studies suggest that low-dose steroids 
may lower this risk. Another con- 
cern for elderly patients and those 
with underlying cardiac disease 
or severe thyrotoxicosis is the 
temporary worsening of symptoms 
as radioiodine destroys the gland. 
Doctors often pre-treat this group 
with antithyroid medications to 
minimize the risk. 
"We are just speeding up the 
natural process of GD," says 
Greenspan. "The added benefits 
are a shortened duration of symptoms 
and less risk of complications from 
sustained antithyroid medication 
use. All we have done is to acceler- 
ate the process already underway 
but, in doing so, we have cured 
the disease." 
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PROPER PRECAUTIONS 
Greenspan emphasizes that 
an uptake test must always be 
obtained before treatment begins. 
Occasionally patients will have 
uptakes in the normal range and, 
although subacute disease may be 
present, they should not be treated 
for two reasons: the possibility 
of another diagnosis; and, with 
normal uptake, the need for three 
Most important in determining 
dosage, says Greenspan, is not to 
lose sight of the goal of radiotherapy: 
"While saying that thyroid activity 
should be reduced to a normal 
level is plausible, in reality it is very 
hard to do. It is prudent to slightly 
overestimate the amount of 
radioiodine needed rather than 
try to give the exact dose, fall 
short, and then retreat." 
^V..While saying that thyroid activity should be 
reduced to a normal level is plausible, in reality it is 
very hard to do... 99 
to five times the usual dose of 
radioiodine to achieve therapeutic 
concentrations in the thyroid gland. 
While some medical facilities 
use a fixed-dose method, Mallinckrodt 
Institute radiologists calculate the 
radioiodine dose to allow the high- 
est likelihood of treatment success 
using the least amount of 1-131. 
Patients with high uptake ranges 
can be effectively treated with 
lower doses of radioiodine, as 
more of the isotope reaches the 
gland. In contrast, patients with 
larger thyroids need a higher dose 
of radioiodine to effectively reduce 
the gland's function. 
FOR MORE INFORMATION 
National Graves' Disease 
Foundation: www.ngdf.org 
American Thyroid Association: 
www.thyroid.org 
As with 1-123 studies, there are 
some precautions: 
• Discontinue use of antithyroid 
medications and iodine-rich 
agents prior to radiotherapy. 
• Do not administer 1-131 to preg- 
nant patients due to the risk of 
fetal thyroid damage and death. 
• Avoid pregnancy for one year 
after treatment. 
• Have a negative pregnancy test, 
ideally the day of or day prior to 
treatment, required for women of 
child-bearing age. 
• Nursing mothers must stop 
breastfeeding their infants three 
to four weeks before treatment 
and cannot resume post-therapy. 
MAXIMIZING SAFETY OF OTHERS 
The practice mandate called 
ALAEA—"As Low As Reasonably 
Achievable"— indicates minimizing 
radiation exposure to only that 
needed for diagnosis or treatment. 
Although any theoretical risk is 
small, anyone exposed to a treated 
patient before the radioiodine is 
cleared from the body incurs risk 
without benefit—an undesirable 
risk-benefit ratio. Exposure is 
minimized with a few simple mea- 
sures: time, distance, and hygiene. 
• Exposure in one minute is one 
tenth of the amount of exposure 
in 10 minutes, and a distance 
twice as far from the radiation 
source results in one quarter of 
the exposure. 
• Sitting across the room from a 
treated patient for a few minutes 
is significantly less exposure than 
sitting on that person's lap for the 
same few minutes. 
• If the car ride home is more than 
two hours, the patient may want 
to sit in the back seat, opposite 
the driver's side. 
• Because radioiodine is excreted 
in urine, feces, and perspiration, 
good hygiene can also reduce 
unnecessary exposure to others, 
including laundering clothing, 
bed linens, towels, and utensils 
separately from those of other 
family members; showering daily; 
washing hands frequently; and 
flushing the toilet two to three 
times after voiding. 
• Physicians also recommend that 
patients abstain from having sex- 
ual intercourse for three to four 
days after treatment. 
• Patients should avoid contact 
with pregnant women and young 
children, especially infants, for 
at least one week. 
Radioactive iodine fills a gap in 
treating GD by providing an option 
other than surgery or medications 
with high failure rates. Greenspan 
concludes, "Quite frankly, radioac- 
tive iodine is a very effective and 
safe treatment for Graves' disease. 
I would choose this option for 
myself and my family members if 
the need arose. If done with proper 
precautions and appropriate dose 
calculation, it works." EH3 
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RESOLVING THE MYSTERIES OF 
In Mallinckrodt Institute of Radiology's 
East Building, what was a technologically sophisticated 
but otherwise plain magnetic resonance imaging 
(MRI) suite has been converted into a cozy nursery with 
rocking chairs, a crib, and blankets. Customized to 
accommodate an uncommon group of study 
participants, it's the site of seminal research 
into autism, and the pioneering 
subjects are just six months old. 
RESOLVING THE MYSTERIES OF 
AUTISM 
The infants arrive in the evening 
to be rocked and cuddled by their 
parents, then put comfortably to 
bed—in the bore of the scanner. 
For as long as 10 days before their 
imaging appointment, the infants 
have become accustomed to the 
subdued knock, buzz, and beep of 
the high-tech imager as their par- 
ents have played them a tape of the 
noises they'll hear during the scan- 
ning process. The babies wear little 
earplugs, under noise-shielding 
headphones. And after they're 
deeply asleep and perfectly still, 
late-night scans record exquisitely 
detailed images of their heads and 
brains. They are exposed to no 
radiation and need no anesthesia 
or injection of contrast agents. 
The research is so noninvasive 
and unobtrusive that the babies 
often sleep right through it. If they 
fuss a little, the scanning pauses; if 
ley wake, the session ends. Their 
parents agree to participate even 
*   *■! 
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though they probably have their 
hands full with both an autistic 
child and a new baby. That's one 
measure of how deeply committed 
they are to resolving the mysteries 
of autism. 
DIAGNOSTIC IMAGING AND 
EARLY INTERVENTION 
The infants offer invaluable 
insights to the research team 












than are the 
population at 
large. The 
tender age of 
the subjects 





early brain development," says 
Kelly Botteron; MD, associate pro- 
fessor of psychiatry and of radiol- 
ogy. "Early intervention is where 
the future of autism treatment lies." 
Today, by the time a diagnosis 
of autism is stable, the effective- 
ness of intervention may already 
have been limited. To help 
change that, the youngsters are 
participating in a five-year 
national study funded by the 
National Institutes of Health- 
sponsored Autism Centers of 
Excellence (ACE) Network. 
Summarizing the goal of the 
research, Botteron, the principal 
investigator of its St. Louis arm, 
says it will "relate images of the 
infants' developing brains to the 
diagnosis of autism," helping to 
understand the underlying neuro- 
physiology and provide a target for 
further research. "A study connect- 
ing imaging to diagnosis has never 
been done in infants before," 
she says. 
Kelly Botteron, MD: "MRI offers the unique opportu- 
nity to noninvasively study structural and functional 
neural development in vivo in young children." 
The children—who will be 
scanned at six months, 12 months, 
and 24 months of age—will be 
joined by a control group of identi- 
cally aged, healthy youngsters with 
no predisposition to autism. All of 
the youngsters will likewise be 
carefully tested to either make a 
diagnosis of autism or rule it out. 
Any abnormalities revealed by the 
scans can then be associated with 
developing autism and perhaps to 
the wider range of related disorders 
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known as autism spectrum disor- 
ders (ASD), providing new insights 
into those conditions as well. 
Because the brain is developing so 
rapidly during these early days of 
life, the researchers face the chal- 
lenge of making sure all subjects 
are scanned and cognitively tested 










will be able 




and they ask 
for help in spreading the word 
about their need for families that 
have infants or babies on the way 
and an autistic older child. 
Previous studies of head circum- 
ference have demonstrated a 
relationship between general brain 
overgrowth and autism, Botteron 
says, but despite increasing interest 
in understanding autism, sophisti- 
cated imaging studies have been 
surprisingly few. In fact, until 
recently, many researchers believed 
it was not possible to get accurate 
and reliable images of such tiny 
and sometimes uncooperative 
subjects, she says. 
ADVANCED TECHNOLOGY 
The techniques the investigators 
will use to safely and effectively 
image the young subjects have been 
developed over years of experience 
at Washington University and 
Mallinckrodt Institute. Robert 
McKinstry, MD, PhD, associate 
professor of radiology and of pedi- 
atrics, participated in devising the 
While this MRI scan was being 
done, the sleeping infant quite 
naturally was sucking his thumb. 
ABOUT AUTISM 
Autism is a neurobiological developmental disorder usually diag- 
nosed by three years of age. It interferes with a person's ability to 
communicate, the capacity to relate to others and cognitive function. 
Those with autism often display repetitive motions and follow rigid 
routines. Autism carries a strong genetic component, but the genetics 
of the disorder are complex and not well-understood. 
It lasts throughout a lifetime but does not shorten life expectancy, 
although people with autism often suffer from a number of physical 
ailments including recurring infections, asthma, and digestive 
disorders. There is no cure, but early intervention can reduce the 
severity of symptoms, and behavioral or cognitive intervention can 
help children gain self-care, social, and communication skills. 
Autism is one of a group of disorders known as ASD, for autism 
spectrum disorders, with a wide range of symptoms and severities. 
Together, autism spectrum disorders affect an estimated 1.5 million 
Americans, according to the Autism Society of America (ASA). 
Controversy exists over just how rapidly the incidence of autism is 
increasing. Improved diagnostic procedures contribute to larger 
numbers, but there also appears to be an actual rise in the number 
of cases. According to the group Autism Speaks, prevalence has 
risen until one in every 150 children is diagnosed with autism, 
making it more prevalent than pediatric cancer, diabetes, and AIDS 
combined. It affects boys disproportionately. 
A diagnosis of autism can be life changing for a family; frequently, 
one parent must devote full time to providing care. The lifetime cost 
of that care has been estimated at between $3.5 million and $5 
million. In the United States, all autism-related expenses may be as 
high as $90 billion annually, according to the ASA. 
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RESOLVING THE MYSTERIES OF 
AUTISM 
sedative-free scanning of infants 
during a 1999 to 2007 national MRI 
study of normal brain develop- 
ment. So far in the autism study, 
the protocol has been used to scan 
the first five young subjects, with 
unqualified success. 
McKinstry, who is chief of 
Mallinckrodt Institute's Pediatric 
Radiology section, also designed 
the imaging protocol and scanning 
implementation for the autism 
study. High-speed MRI is capable 
of structural neuroimaging—the 
capacity to visualize parts of the 
brain such as the amygdala and the 
frontal centers where facial pro- 
cessing occurs, both areas of con- 
cern to autism researchers. The 
technology reveals the volume and 
shape of the brain's gray matter, 
made up of nerve cell bodies. 
But the latest evolution of 
sophisticated MRI technology, 
called diffusion tensor imaging 
mi 
(DTI), goes a big step further. DTI 
reveals the secrets of white matter, 
the long tentacles of nerve cells 
(or axons) that compose the wiring 
connecting the various parts of the 
brain. "DTI images the microstruc- 
ture that carries signals, showing 
whether the wires are properly 
organized, aligned, and insulated," 
McKinstry says. "We can follow 
them from one point in the brain 
to another and test whether the 
connections play a role in autism." 
DTI uses radio waves and 
magnetic pulses to nudge water 
molecules in the brain. Water in the 
axons is constrained by the myelin 
sheaths that protect them, much 
like a wire's insulation, so it tends to 
move along the wire rather than dis- 
persing in every direction like water 
molecules elsewhere. By making 
images of the water's organized 
movement, investigators can map 
the wires and locate their terminals. 
A COLLABORATIVE EFFORT 
The researchers will make 
scans of the 100 infants with autis- 
tic older siblings whom they hope 
to enroll in St. Louis, plus the 
control group. Similar efforts at the 
University of North Carolina, the 
University of Washington at Seattle, 
and the University of Pennsylvania 
will bring the total number of 
infants scanned to 400, along with 
160 healthy, contrast subjects. 
The large majority will not go on to 
develop autism, but perhaps 60 of 
the youngsters are expected to be 
diagnosed with the disorder, given 
established statistics. Data from 
the four centers then will be 
collected and analyzed at two 
additional coordinating centers at 
the Montreal Neurologic Institute 
and the University of Utah. To 
recruit qualified participants who 
can visit at precise times requires a 
region-wide effort, Botteron says, 
and support groups such as Autism 
Speaks are helping by alerting their 
highly motivated members. 
CHALLENGES AND 
POSSIBLE SOLUTIONS 
Another challenge faced by 
the researchers is making accurate 
autism diagnoses at very young 
ages. John Constantino, MD, who 
brings a large autism research port- 
folio to the study, says that many in 
the field believe that the symptoms 
of autism must be appreciable at 
even six months, but "we're just 
not sure." For those youngest chil- 
dren, he will observe and archive 
video recordings that can be revis- 
ited for even the most subtle clues. 
And he will use the still-face para- 
digm, in which a caregiver who has 
been interacting with a child 
quickly disengages; the sudden 
I 
Left: In this autism study, Dr. Robert McKinstry 
combines his clinical interest in pediatric 
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indifference upsets most normal 
babies, but autistic infants often 
are not bothered, he says. Constan- 
tino, associate professor of psychi- 
atry and of pediatrics, says the 
researchers also may be able to 
employ eye-tracking technology to 
measure precisely where babies 
focus their attention for a "finer- 
grained evaluation." A broader 
range of established tests will be 
used to evaluate the subjects as 
they reach 12 months and 24 
months of age. Finally, Constantino 
will make a firm diagnosis when 
the subjects reach three years, the 
age at which diagnoses are widely 
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The researchers' hope for 
the work is that it will produce 
observable differences in the 
brains of autistic children that can 
serve as a basis for discerning the 
mechanisms by which the disorder 
develops. McKinstry says that, 
ideally, the study could lead to a 
diagnostic tool to be used as a 
means to assess children who may 
be at risk and even become the 
basis for developing strategies to 
limit disability. 
More likely, Botteron says, is 
that the research may eventually 
help to sort out the effectiveness 
of the wide range of treatments 
and interventions that are avail- 
able. Families have several broad 
varieties and dozens of individual 
plans from which to choose 
when considering treatment. 
"Many of the approaches are 
untested, and it would be 
helpful to know which 
ones work," she says. Any 
treatment shown to be 
symptomatically effective 
could be evaluated using 
the study's results to see 
if underlying physiologi- 
cal changes are affected 
by a given treatment. 
For example, the well- 
regarded approach called 
applied behavioral 
analysis (ABA) that is 
generally regarded as a 
successful treatment 
approach could be tested 
to reveal if and how the 
underlying physiology is 







Botteron warns that the size 
of the sample of children who 
eventually develop autism— 
perhaps 60—is small and that 
autism is aggravatingly complicated, 
most likely 
attributable to 
several or even 
many causes, 
and with a 
wide range of 
symptoms and 
severities. 
For one study 
to unravel all 
of its complexi- 







says, and the 
young volun- 
teers who go 
to sleep in 
Mallinckrodt 
Institute's 
scanner are providing a first look 
at the condition as it develops—a 
big step in a promising new direc- 
tion before they can even walk. Ed 
Editor's Note: For more informa- 
tion about participating in this 
important study, go online at 
http-Mnfantsibs-stlouis.org. Or 
call Study Coordinator Lisa Flake, 
MSW, toll free at 1-888-845-6786. 
4 
John Constantino, MD, has 
more than 10 years experi- 
ence in autism research. 
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The National Oncologic 
PET Registry AN IMPORTANT MILESTONE 
by Candace O'Connor 
egistry (N( 
began accruing patients in May 2006, has reached an 
important milestone with exciting results. In March 
_*■      2008, the NOPR announced that, based on the findings 
of PET scans performed with the radiotracer F-18 fluorodeoxyglucose 
(FDG), clinicians at more than 1,200 facilities around the 
country—participants in this sweeping effort to measure the effect 
of positron emission tomography (PET) findings on treatment 
decisions—had changed the care of 36.5 percent of the 23,000 
registered cancer patients. 
Now this data has been submitted to the Center for Medicare 
and Medicaid Services (CMS), which will begin a review process 
to determine whether these findings should lead to coverage of 
more forms of cancer. Currently, CMS only covers PET scans for 
certain cancers—ovary, uterus, prostate, pancreas, bladder, kidney, 
stomach, and others-|-among patients who receive their scans at 
facilities that participate in the Registry. 
The impact of FDG-PET 
comes as no surprise to 
Arizona resident Laurel 
Pracht, now 62, who was 
diagnosed with late-stage ovarian 
cancer in 1999. She had surgery 
and chemotherapy, but it was hard 
to determine whether she had 
residual cancer because her tumor 
did not express the usual tumor 
marker, CA-125.   When Pracht's 
oncologist warned her to get her 
affairs in order, based on the find- 
ings of a computed tomography 
(CT) scan and an elevated tumor 
marker, she paid the out-of-pocket 
cost for a PET scan that showed no 
cancer! A sixth round of planned 
chemotherapy was canceled. 















uurel Pracht: I would not ^ Registry, 
have pad for my own PET scans     ghe h&d 
had I not thought the results paidoutof 
would d.rectly assist in the pocketfortwo 
management of my disease." pET gcans 
"My survival is due to skilled 
medical care, a good response to 
chemotherapy, being an educated 
patient, and not being denied PET 
scans, proven in my case to be 
cost-saving and accurate," says 
Pracht, a vocal advocate for PET 
l#* 
? 
scan coverage. "Cancer patients 
should not be more concerned 
about making an installment pay- 
ment on the cost of a scan than 
about how long they have to live." 
Mallinckrodt Institute's Role 
The success of the NOPR in 
completing this innovative "coverage- 
with-evidence-development" study 
also comes as no surprise to Barry 
Siegel, MD, cochair of the NOPR 
working group. Siegel, professor 
of radiology and of medicine, has 
been a key advocate and organizer 
of the NOPR, which was sponsored 
by the Academy of Molecular 
Imaging (AMI) and managed by 
the American College of Radiology 
through the American College of 
Radiology Imaging Network 
(ACRIN). He believes that the 
Registry's decisive results should 
substantially change the coverage 
policy of CMS, which is now 
reviewing the NOPR data in a 
process that includes a six-month 
analysis to produce a draft decision, 
then another analysis period to 
create a final decision. 
"The NOPR was launched suc- 
cessfully, has accrued successfully, 
and has made PET accessible to a 
large number of patients," says 
Siegel, who is also deputy cochair 
of ACRIN and medical director of 
its PET Imaging Core Laboratory. 
"We believe it has generated 
compelling data that we hope will 
convince Medicare that much 
broader coverage of PET than 
is currently available is indeed 
reasonable and necessary." 
On March 24, Siegel and his 
colleagues published their findings 
in the on-line version of the Journal 
of Clinical Oncology; the print 
version appeared on May 1. Also 
in March, they submitted a recon- 
sideration request to CMS, asking 
Barry Siegel, MD: "The ultimate accomplishment would 
be broad coverage for diagnosis, staging, and restaging 
for all cancers as well as treatment monitoring." 
the agency to provide coverage for 
the diagnosis, staging and restaging 
of all cancers except three, already 
listed as "nationally non-covered": 
diagnosis of breast cancer when 
an abnormality is present by 
mammography or palpation, and 
regional node assessment in breast 
cancer, and malignant melanoma. 
Background of the Study 
While other forms of imaging— 
especially magnetic resonance 
imaging (MRI) and CT—have long 
been covered for cancer patients, 
PET has not. More than a decade 
ago, the agency that preceded CMS 
in administering Medicare 
considered covering PET broadly 
I 
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PET Registry] r AN IMPORTANT 
but decided against it, because it 
was concurrently adopting regula- 
tions that would require scientific 
evidence to prove that new tech- 
nologies improved patient out- 
comes. 
So the agency instead decided 
to approve PET only for certain 
types of cancer: 
• 1998—evaluation of lung nodules 
and the initial staging of non-small- 
cell lung cancer 
• 1999—restaging of patients with 
recurrent colorectal cancer, some 
lymphoma cases, and possible 
recurrence of melanoma 
•2000—diagnosis, staging, and 
restaging of non-small-cell lung 
cancer, lymphoma, malignant 
melanoma, esophageal cancer, 




•2003—partial coverage for restaging 
of various thyroid cancers. 
Still, many physicians felt 
frustrated by these limitations 
since they believed in a much 
broader use of PET; in 2002 the 
AMI acted, encouraging medical 
centers to petition for more cover- 
age. Nine institutions responded, 
including Mallinckrodt Institute, 
where Siegel and Perry Grigsby, 
MD, professor of radiation oncology, 
of radiology, and of obstetrics and 
gynecology, requested coverage for 
cervical cancer. In 2004, CMS 
decided to approve only cervical 
cancer, but the agency also 
announced that it would consider 
covering other cancers as part of a 
large-scale "coverage-with-evidence- 
development" effort to evaluate 
PET's effectiveness. 
How the NOPR Worked 
Siegel and his colleagues began 
discussing this idea and came up 
with the plan for a registry. They 
contacted the American College of 
Radiology and asked whether its 
imaging network, ACRIN, could 
provide the necessary infrastruc- 
ture. Other key groups, including 
the American Society of Clinical 
Oncology and the Society of 
Nuclear Medicine, also offered 
support. Substantial funding came 
from the AMI, through its Institute 
for Molecular Technologies. 
Medicare-eligible patients 
could participate when they came 
in with a referral for a PET scan 
to evaluate a form of cancer not 
otherwise covered by Medicare. 
Before the test, the facility had to 
collect, from the referring physician, 
a pre-PET questionnaire, indicating 
planned treatment without PET 
data; afterwards, another question- 
naire assessed the physician's 
treatment plan in light of FDG- 
PET findings. All information was 
collected electronically through 
the NOPR Internet site. 
The NOPR organizers spent 
hours educating PET facility 
personnel and referring physicians 
about data collection and about the 
uses and misuses of PET. Despite 
minor bumps, the process went 
"quite smoothly," says Siegel. "It 
exceeded our expectations as to 
how smoothly it ran." 
\l 
VII 
PET and Cancer 
Although FDG-PET is a valuable 
tool in diagnosing or staging cer- 
tain forms of cancer, says Siegel, 
there are forms of cancer in which 
it may be less sensitive than other 
imaging methods. It does not do 
particularly well with the diagnosis 
or initial staging of prostate cancer, 
liver cancer, or "mucinous cancers" 
such as stomach cancer. 
Yet in this study, "we have 
drilled down and do not find that 
there are any cancers for which 
PET is an exceptionally outstanding 
performer or exceptionally poor 
performer in terms of changing 
management," he says. Overall, he 
believes it is an effective tool for 
many cancers, so Medicare should 
trust physicians, and the radiologists 
who advise them, to understand 
PET's limitations and to use PET 
whenever appropriate. 
In this study, PET also showed 
one surprising result in patients for 
whom a biopsy was being planned 
to evaluate their cancers. In some 
three quarters of these patients, the 
PET scan eliminated the need for 
this procedure. 
Does PET save lives? 
Although the NOPR findings 
demonstrate that PET has a sub- 
stantial effect on the way in which 
physicians treat cancer patients, 
does that translate into more lives 
saved? Intuitively, most people 
might guess that it does. But so far, 
says Siegel, no hard data exist to 
show that using PET leads to a pro- 
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longed life span for cancer patients. 
Existing studies do show that 
PET allows doctors to find certain 
recurrent cancers at an earlier-and 
presumably more treatable-stage 
than they would have been other- 
wise. In fact, this early detection 
has sometimes allowed surgeons 
to perform a complete surgical 
removal of the recurrence. 
Clearly, PET also has another 
advantage: It gives both physicians 
and patients the chance to "con- 
serve resources." For example, 
pancreatic cancer, caught early 
enough, can be treated surgically 
with the "Whipple procedure," an 
extensive operation with a difficult 
recovery period. 
"But if you look at the PET 
scan, and find that the patient has 
distant metastatic disease, then 
PET findings have steered the 
patient away from radical therapy 
that is intended to be curative but 
that cannot be curative," says Siegel. 
In the future, PET may also be 
useful in the area of treatment 
monitoring. After a patient has had 
one or more cycles of chemother- 
apy, what effect is it having? It 
may be too early for CT scanning 
to have shown any response. By 
assessing the cancer's metabolism 
rather than its size, PET is usually 
able to determine early on if the 
drug is not working, thus conserving 
expensive medications, conserving 
the patient's strength, and allowing 
the patient to shift to a drug therapy 
that may work better. 
"That is the whole concept of 
using molecular imaging for what 
has been called individualized med- 
icine but may be more correctly 
labeled 'risk-stratified medicine,'" 
says Siegel. "We may not be certain 
that our answer will work for a 
patient all of the time, but we 
enrich the probability that it is the 
right one because we have shown, 
metabolically, that the patient is in 
the responder group rather than 
the non-responder group." 
Future of NOPR Findings 
The CMS review process 
should be complete by January 
2009, with a report issued detailing 
the new guidelines. Meanwhile, 
CMS coverage of PET scans for 
cancer patients who have Medicare 
coverage continues during the 
more than 87,700 patients have 
received scans covered under the 
Registry to date. 
The NOPR working group is 
hopeful about the outcome, and 
patients like Laurel Pracht are 
eager for a positive decision. 
Within her on-line support group of 
ovarian-cancer survivors, some 
have had PET scans that changed 
their course of treatment. "Others 
have died, while making install- 
ment payments on the cost of their 
scans," she says. 
"Doctor Siegel has stayed the 
course, taking the NOPR from an 
idea to the first collaboration 
between the private medical imag- 
ing sector and CMS," says Pracht. 
"He and the committee were fully 
aware that patients were divided 
into those who could afford the out- 
of-pocket cost for this diagnostic 
tool and those who could not-and 
they have directly benefited this 
patient's future." EM 
The NOPR Working Group 
- Barry Siegel, MD, professor of radiol- 
ogy and of medicine; chief, Division of 
Nuclear Medicine—Mallinckrodt Insti- 
tute of Radiology at Washington 
University School of Medicine 
• Edward Coleman, MD, professor of 
radiology; chief, Division of Nuclear 
Medicine—Duke University School of 
Medicine 
• Bruce Hillner, MD, professor of 
internal medicine; associate chair, 
information systems—Virginia 
Commonwealth University 
• Anthony Shields, MD, PhD, professor of 
medicine and of oncology—Wayne 
State University; director, clinical 
research—Karmanos Cancer Institute, 
Detroit, Michigan 
• The Statistical Center—Brown University. 
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RADIOLOGY   IN   THE   ROUGH 
ON DUTY IN IRAQ 
by Mary Jo Blackwood, RN, MPH 
Most radiologists at Mallinckrodt Institute of Radiology (MIR) probably 
don't think twice about the diagnostic technology available at MIR— 
they're accustomed to having multiple units of cutting-edge equipment 
on hand to provide the highest quality care for patients. Matthew 
Parsons, MD, assistant professor of radiology in the Institute's Neuro- 
radiology section, now has a new appreciation for these ready 
resources after his stint in Iraq at the 325th Combat Support Hospital 




"We did our work at the hospital 
with two CT [computed tomography] 
scanners, an X-ray unit, and an 
ultrasound," says Parsons. "There 
was no MRI [magnetic resonance 
imaging] or PET [positron 
emission tomography]." 
Parsons joined the Army 
Reserve in September 2000, was 
activated in August 2007 and sent 
to Iraq. He served 100 days as the 
only radiologist in the hospital at 
Al Asad (Arabic for "The Lion") Air- 
field, approximately 180 kilometers 
west of Baghdad and the largest 
United States military airbase in the 
mostly Sunni-populated, western 
Iraq province of Al Anbar. When 
Parsons arrived at the hospital and 
met the radiologist he was replac- 
ing, they discovered they had been 
medical students together at the 
University of Cincinnati. Radiologists, 
a scarce specialty in the military, 
are required to serve for 100 to 110 
days during one stint, with proba- 
ble redeployment of 18 months to 
two years between tours of duty. 
Left: Parsons' office was a 
subdivided module, containing 
a desk and two laptops for 
viewing digital radiology images. 
Below: Abraham's Well at Al 
Asad: According to theologians, 
Abraham—who is referenced in 
literature of the Muslim, Jewish, 
and Christian religions—stopped 
at this oasis while travelling 
from Mesopotamia (modern-day 
Iraq) to the land of Canaan. 
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AL ASAD AIR BASE 
The 325"1 is the primary United States 
military healthcare facility in Al Anbar 
province, the site of nearly 40 percent of 
all United States casualties in the Iraq war. 
Before the 325th opened, patients requiring 
Level III surgical care had to be evacuated 
to hospitals in Baghdad, Iraq's capital, or 
Balad, a primarily Shiite town 50 miles 
north of Baghdad. The 325,h's location 
significantly decreased amount of time 
it took to get patients to an advanced 
surgical and stabilization care facility. 
The first pieces of the 32-bed hospital 
arrived in Al Asad in January 2007. The 
modular structure allowed for rapid 
construction, and the facility was finished 
in about two months. It was the first 
United States medical facility to be built 
from the ground up in Iraq. The hospital's 
constructed from separate modules 
hooked together; the modules can be 
subdivided by adding walls to make 
additional rooms. Interior walls are simi- 
lar to dry-erase boards and are often used 
for recording patient care information. 
:
 V. 
Above: Helicopters bring the wounded and those needing 
medical care to the 325th CSH. 
Photos courtesy of Matthew Parsons, MD 
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ON DUTY IN IRAQ 
ON THE JOB 
The 325'" is staffed by United 
States military and, according to 
Parsons, the only Iraqi nationals 
who work there serve as transla- 
tors. Parsons'job description was 
simple: interpret all films and be on 
call 24/7. While stationed at Al Asad, 
he received and read films transmit- 
ted by satellite from Tikrit Airbase 
(100 miles northwest of Baghdad) 
and handled trauma cases. 
While he may not have had as 
much equipment as is readily avail- 
able at Mallinckrodt Institute, the 
equipment Parsons did have saved 
lives. "Radiology is crucial to sur- 
vival in Iraq. For example, when 
people were brought to the hospital 
after being injured by a car bomb 
or by a suicide bomber wearing an 
IED [Improvised Explosive 
Device], I could determine the 
extent of the injuries and if surgery Each choo is roughly eight feet by sixteen feet and 
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was needed," says Parsons. "The 
hospital there couldn't function 
without radiology; its absence 
would result in more—and perhaps 
less accurate—surgery being done. 
I could tell the surgeons where the 
fragments were, which could 
decrease the need for exploratory 
surgery, or I could pinpoint the sur- 
gical target. Our CT scanners were 
crucial for that job. With diagnostic 
imaging, it was possible to pinpoint 
the shrapnel relative to sensitive 
structures, so we could determine 
whether surgery was required." 
"Our rule for accepting people 
at the hospital: If life, limb, or 
eyesight was at risk, they were 
seen. That included United States 
service men and women, Iraqi 
soldiers, Iraqi civilians, government 
contractors, and people from other 
countries who happened to be there." 
The hospital also ran an outpatient 
clinic for noncombat-related minor 
injuries, which often included 
sports injuries from running, bas- 
ketball, football, or soccer. Imaging 
helped to nail down the causes and 
treatment options. 
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LIFE ON THE BASE 
Most of the housing units on 
base are called "choos," explains 
Parsons. "The choo that I shared 
with another doctor had two beds, 
two desks, a TV, and a DVD player. 
We had satellite cable for the 
Armed Forces Network, so we got 
Monday Night Football on Tuesday! 
There was also an Internet connec- 
tion. And, we had an air-conditioner, 
which is pretty much a necessity 
when you're living in a metal box in 
a country where the daily temperature 
can reach 130 degrees Fahrenheit. 
The hospital and the two large dining 
facilities also were air-conditioned." 
Commuting to work was no 
problem. "My living quarters were a 
quarter of a mile from the hospital, 
and the two dining facilities were 
each about one mile away. The 
highlight of my day was lunch and 
dinner," Parsons says with a smile. 
"I walked everywhere and felt very 
safe, partially because all person- 
nel on the base are required to 
carry side arms." 
Parsons took his laptop com- 
puter and a digital camera to Iraq, 
so he could send pictures home 
over the Internet. He was able to 
call his wife almost everyday. "The 
only exception was when a soldier 
died," Parsons says. "No one was 
allowed to send e-mails or call 
home until the military had notified 
the soldier's family in the correct 
compassionate way." Once a week, 
Parson had a video conference call 
with his wife and 14-month-old son 
Jack. "My wife said that because of 
the video calls, Jack thought his 
daddy lived in the computer." 
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RADIOLOGY CASES FROM AL ASAD 
Head CT scan of a 
latient who was 
'njured by an 
Improvised Explosive 
Device (IED) blast. 
( } 
\ 3 
CT scan of a Marine, 
with symptoms of 
nausea, vomiting, / ^v 
and persistent / 
leadache, reveals a / %/     1 
six-centimeter tumor 1 1 
n the frontal lobe 
of his brain. He ^■f   mM I       '1 
was transferred to 1     i ll 
a hospital in m i 
the States. i *s 
A United States ■ 
government contrac-                     ^ ^ f^t^. 
^M ^^ 
history of breast                   ^L\ 
^ cancer was suffering            Am 
from severe                       Am 
leadaches. After a            km 1 
CT image showed            mm *dr 1 jrain metastases,            ^B 5* J 
she was sent to               ^^ i 
the States for                   ^^bw T*     M 
treatment.                           ^H 
\- 
Left: This house belonged to a date farmer 
whose land was confiscated during Sadaam 
Hussein's presidency; the land became part 
of an Iraqi Air Force base called Al Asad. 
I 
TEAMWORK 
When asked about his memo- 
ries of his time in Iraq, Parsons says 
that it is hard to forget the extreme 
heat and that all the surroundings 
seem to be in shades of tan or 
brown, no greenery or color. "But I 
think mainly it's the doctors I 
worked with," he adds. "We really 
were a team. I keep in contact with 
some of the other physicians; one 
of them from San Francisco came 
here for a visit. They were very 
professional and treated everyone 
with the same courtesy and care— 
military officers and Iraqi citizens 
alike. It was a great example of 
the phrase: 'Medicine knows 
no boundaries.'" EH 
Matthew Parsons, MD, (kneeling, fifth from the left) 
and the physicians of the 325th Combat Support 
Hospital, Al Asad. 
*« 
A MEMORABLE CASE 
A young Marine and his canine 
partner, Leah, were on patrol in 
Fallujah, about 40 miles west of 
Baghdad, when a suicide bomber 
detonated an IED next to them. 
Most of the bombers fill their vests 
with either nails or ball bearings to 
do the most damage—this one had 
used ball bearings. "The Marine 
had facial injuries," says Parsons. 
"We used CT to scan his head, 
neck, and face, 
which showed 
V        that a ball bear- 
ing had fractured 
his mandible and 
was lodged near 
the carotid artery. 
CT of the young Marine 
shows the ball bearing 
lodged near the internal 
carotid artery. 
The CT scan located the ball 
bearing so precisely that we 
were confident it could safely 
be left in place without causing 
more injury. It saved the 
Marine from having exploratory 
surgery to a delicate area." 
Leah, on the other hand, 
seemed to have only superficial 
wounds on the chest and 
abdomen, but she was acting as 
though she was badly injured. 
"So I performed my first ever 
CT scan of a dog and discov- 
ered she had a ruptured spleen 
and damaged bowel," says 
Parsons. Leah was taken to the 
OR so surgeons could repair the 
bowel and remove the spleen. 
The dog recovered but was 
retired from active duty and 




Above: An anesthesi- 
ologist readies Leah 
for a CT scan. 
CT scan reveals blood 
around Leah's spleen, 
which was severed into 
two parts. 
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In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology are highlighted in boldface type. 
NEW FACULTY 
Kristopher Cummings, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology. 
Michelle Lee, MD, instruc- 
tor in radiology, Division of 
Diagnostic Radiology. 
Nael Saad, MD, instructor 
in radiology, Division of 
Diagnostic Radiology. 
Darryl Zuckerman, MD, 
assistant professor of radiol- 




Carolyn Anderson, PhD, 
professor of radiology, of 
molecular biology and phar- 
macology, and of chemistry, 
was appointed professor of 
biochemistry, Department of 
Biochemistry and Molecular 
Biophysics. 
GRANTS 
Kevin Black, MD, associate 
professor of psychiatry, of 
neurology, of radiology, and 
of anatomy and neurobiology, 
received a one-year grant in 
the amount of $61,825 from 
the Tourette Syndrome 
Association for "Finding tics 
in the community without 
f   putting a doctor on every 
corner." He received a one- 
year grant from Synosia 
Therapeutics for "A random- 
ized, double-blind, placebo- 
controlled, two-way cross-over 
study to explore the effects 
of 7 days dosing with 
SYN115 20mgp.o. BID or 
60 mg p.o. BID on clinical 
and fMRI response to intra- 
venous levodopa in patients 
with mild to moderate 
Parkinson's disease." 
Colin Derdeyn, MD, 
professor of radiology, and 
of neurology and neurological 
surgery, is the principal 
interventional neuroradiology 
investigator for a $27 million 
grant from the National 
Institute of Neurological 
Disorders and Stroke 
(NINDS) for research on 
"Stenting vs. aggressive 
medical management for 
preventing recurrent stroke 
in intracranial stenosis 
(SAMMPRIS)." Marc Chi- 
mowitz, MBChB, Medical 
University of South Carolina, 
is principal investigator for 
the five-year multicenter 
study. Derdeyn serves as 
chair of the Advisory Com- 
mittee for the six-year, 
$1.9 million NINDS-funded 
"Vertebrobasilar flow evalua- 
tion and risk of transient 
ischemic attack and stroke 
(VERITAS) Study." Sepideh 
Amin-Hanjani, MD, University 
of Illinois, Chicago, is princi- 
pal investigator. Derdeyn is 
coinvesrjgator for the four-year, 
$4.2 million NINDS-funded 
"Carotid occlusion surgery 
study." Principal investiga- 
tors are William Powers, MD, 
University of North Carolina, 
and Robert Grubb, Jr., 
MD, professor of neurologi- 
cal surgery and of radiology. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology, is the study center 
principal investigator for the 
American College of Radiol- 
ogy Imaging Network (ACRIN) 
Protocol 6677 "Staging with 
MR perfusion imaging and 
MR spectroscopy." ACRIN 
6677 is being conducted in 
collaboration with the Radia- 
tion Therapy Oncology 
Group Protocol 0625, "A 
randomized phase II trial 
of bevacizumab with 
temozlomide in recurrent 
glioblastoma." Funding for 
the study is on a per-subject 
basis, with current funding 
at $34,174. 
Suresh Vedantham, MD, 
associate professor of 
radiology, as principal inves- 
tigator, received a five-year, 
$7.2 million grant from the 
National Heart, Lung and 
Blood Institute, National 
Institutes of Health, for 
research on "Pharmacome- 
chanical catheter-directed 
thrombolysis for acute DVT." 
Karen Wooley, PhD, pro- 
fessor of chemistry and of 
radiology, received a three- 
year grant in the amount of 
$443,917 from the Office of 
Naval Research for "The 
development of non-toxic 
anti-fouling coatings based 
upon nanoscopic surface 
complexities." She is a coin- 
vestigator for a five-year 
grant in the amount of $9.3 
million from the National 
Institutes of Health for 
research on "Targeted 
nanoparticles optimized 
for cancer diagnosis and 
therapy." She is a coinvesti- 
gator for a five-year, $1.9 
million grant from the 
National Institutes of Health 
for research on "Adhesin- 
based nanotherapeutics in 
urinary tract infection." 
APPOINTMENTS/ 
ELECTIONS 
Deanna Barch, PhD, 
associate professor of 
psychology, of psychiatry, 
and of radiology, was named 
director of the Silvio Conte 
Center for Neuroscience 
Research at Washington 
University in St. Louis. 
Mikhail Berezin, PhD, 
instructor in radiology, was 
appointed to the program 
committee for the 2009 SPIE 
International Symposium of 
Biomedical Optics. 
Colin Derdeyn, MD, 
professor of radiology, and 
of neurology and neurological 
surgery, was appointed to 
the Clinical Neuroscience 
and Disease Study Section 
of the National Institutes of 
Health's Center for Scientific 
Review. He was appointed to 
a four-year term as a consul- 
tant to the Neurological 
Devices Panel of the Medical 
Devices Advisory Committee 
of the Food and Drug Admin- 
istration's Center for Devices 
and Radiological Health. He 
also was appointed to a five- 
year term on the Steering 
Committee of the National 
Institute of Neurological 
Disorders and Stroke 
Specialized Programs for 
Translational Research in 
Acute Stroke (SPOTRIAS) 
Center Network. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, was appointed to 
the Advisory Board of the 
Bauder Center for Business 
Medical Ethics at Saint 
Louis University, St. Louis, 
Missouri. 
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Continued from page 27 
Fred Prior, PhD, research 
associate professor of radiol- 
ogy, was appointed chairman 
of the Georgetown University 
Biomedical Informatics 
External Advisory Board. 
Brian Rubin, MD, PhD, 
professor of surgery and 
associate professor of radiol- 
ogy, was elected president of 
the Midwestern Vascular 
Surgical Society. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
was appointed deputy 
cochair of the American 
College of Radiology Imaging 
Network (ACRIN) and was 
reappointed as medical 
director of the ACRIN PET 
Imaging Core Laboratory. 
Marilyn Siegel, MD, 
professor of radiology and 
of pediatrics, was appointed 
chair of the Radiology 
Committee of the National 
Cancer Institute's Children's 
Oncology Group. 
Jerold Wallis, MD, associate 
professor of radiology, was 
appointed to the Board of 
the Intersocietal Commission 
for the Accreditation of 
Nuclear Medicine 
Laboratories. 
Karen Wooley, PhD, 
professor of chemistry and 
of radiology, was appointed 
to the Review Committee on 
Faculty Personnel Proce- 
dures, Washington University, 
St. Louis, Missouri. 
Pamela Woodard, MD, 
associate professor of radiol- 
ogy, was appointed chair of 
the American College of 
Radiology Imaging Network's 
newly formed Cardiovascular 
Imaging Research Committee. 
LECTURES 
Carolyn Anderson, PhD, 
professor of radiology, of 
molecular biology and phar- 
macology, and of chemistry, 
presented "New radiophar- 
maceuticals for oncological 
imaging" at the Society of 
Nuclear Medicine Mid-Winter 
Meeting, Newport Beach, 
California, February 16. 
She presented "Copper-64- 
labeled biomolecules for 
molecular imaging of cancer 
metastasis" at the Department 
of Chemistry, Virginia 
Commonwealth University, 
Richmond, April 17. 
Kevin Black, MD, associate 
professor of psychiatry, of 
neurology, of radiology, and 
of anatomy and neurobiology, 
presented "Dopaminergic 
modulation of working mem- 
ory in Tourette's syndrome" 
at the American Neuropsy- 
chiatric Association's 19"' 
Annual Meeting, Savannah, 
Georgia, March 1-4. 
Jeffrey Brown, MD, profes- 
sor of radiology, spoke on 
"MR contrast agents: a brief 
history" at the Nebraska 
Radiological Society, Omaha, 
April 23. He presented 
"Gadolinium-based contrast 
agents: summary of existing 
knowledge on NSF" at the 
University of Nebraska Med- 
ical Center, Omaha, April 24. 
Kyle McCommis, research technician, Division of Radi- 
ological Sciences, as lead author, received the Young 
Investigator Award for his presentation on "Detection 
of changes in myocardiai blood flow and volume: a 
CMR study in a canine model of coronary artery 
stenosis" at the Society for Cardiovascular Magnetic 
Resonance (SCMR) 11th Annual Scientific Sessions in 
Los Angeles, California, January 31-February 3. 
McCommis (left) accepts the award from Mathias 
Friedrich, MD, SCMR program chair, and Stefan 
Neubauer, MD, SCMR president. 
As lead author of "Quantification of myocardiai blood 
volume during dipyridamole and dobutamine stress: a 
perfusion CMR study," McCommis also received sec- 
ond-place recognition for the Gerald Pohost Journal of 
Cardiovascular Magnetic Resonance (JCMR) Best 
2007 Manuscript. 
Carmen Dence, MS, 
research associate professor 
of radiology, spoke on "PET 
imaging in nuclear chem- 
istry—role of radiopharmacy 
and applications to nuclear 
medicine" at Atlantico 
University, College of Phar- 
maceutical Chemistry, 
Barranquilla, Colombia, 
February 8. She presented 
"PET imaging in nuclear 
chemistry—applications to 
nuclear medicine" at the 
National Cancer Institute, 
Bogota, Colombia, February 
13. As keynote speaker, 
Dence presented "Role of 
radiopharmacy in PET imag- 
ing and radiochemistry" and 
"Comparison of national 
PET radiopharmaceutical 
regulations" at the 5th 
National Congress of Hospi- 
tal Pharmacy, Bogota, 
Colombia, March 7 and 8. 
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Colin Derdeyn, MD, profes- 
sor of radiology, and of 
neurology and neurological 
surgery, presented 
"Overview of cerebral hemo- 
dynamics" at the 8Ul Annual 
International Meeting on 
Cerebral Revascularization, 
St. Louis, Missouri, January 
10. He spoke on "Natural 
history of North American 
Moyamoya disease" at the 
10th Annual Joint Meeting of 
the American Association of 
Neurological Surgeons/Con- 
gress of Neurological Sur- 
geons Joint Section on 
Cerebrovascular Disease, 
New Orleans, Louisiana, 
February 18. 
Igor Efimov, PhD, professor 
of biomedical engineering 
and of radiology, spoke on 
"Biophotonic imaging of 
atrial pacemaker complex" 
at the Cardiovascular 
Research Seminar, Washing- 
ton University, St. Louis, 
Missouri, January 24. He 
spoke on "Electroporation in 
the intact heart: implications 
for defibrillation, arrhythmia 
and stunning" at Medtronic, 
Inc., Minneapolis, Minnesota, 
January 28. He presented 
"Mechanisms of ventricular 
fibrillation and a new 
approach to cardioversion- 
defibrillation," "New 
approaches for the low 
energy cardioversion and 
defribillation," and "Basic 
electrophysiological mecha- 
nisms of initiation of 
supraventricular tachy- 
arrhythmia" at the VIII Pan 
Slavic International Con- 
gress on Cardiac Pacing and 
Electrophysiology "CAR- 
DIOSTIM," Saint Petersburg, 
Russia, February 15. Efimov 
presented "Functional 
anatomy of the AV junction" 
at the Cardiac Bioelectricity 
and Arrhythmia Center, 
Washington University, 
St. Louis, Missouri, March 
31. He presented "Molecular 
and structural basis of 
arrhythmia in the human AV 
junction: insights from bio- 
photonic imaging" at Cardi- 
ology Grand Rounds, 
University of Cincinnati Col- 
lege of Medicine, Ohio, April 
22. He spoke on "Translation 
of basic cardiac arrhythmia 
research from animal models 
to clinical therapy: need of 
the human heart research" at 
Mid-America Transplanta- 
tion Services, St. Louis, 
Missouri, May 6. 
Louis Gilula, MD, professor 
of radiology, of orthopaedic 
surgery, and of plastic and 
reconstructive surgery, as 
visiting professor, spoke on 
"Analysis of complex carpal 
trauma" and "Radiographic 
entities to know that often 
are not known" at the Uni- 
versity of California, San 
Diego, February 25 and 26. 
As visiting professor, he pre- 
sented "Radiology Board 
Review in musculoskeletal 
system" at the Oregon Health 
and Science University, 
Portland, April 16 and 17. 
Fernando Gutierrez, MD, 
professor of radiology, pre- 
sented "Evolution of CT/MR 
indications: pluses and 
minuses"; "Cardiac anatomy 
on MDCT/MR: normal vari- 
ants"; "Chest pain in the 
ED—the radiologist's role: 
MDCT-triple rule-out?"; 
"Imaging congenital heart 
disease in adults" and "Dis- 
eases of the pericardium" at 
Non Invasive Cardiac Imag- 
ing Review: MDCT, ECHO, 
MRI, presented by Mallinck- 
rodt Institute of Radiology 
and Somascan Medical 
Imaging, San Juan, Puerto 
Rico, February 16 and 17. 
Jay Heiken, MD, professor 
of radiology, presented "CT 
colonography for colorectal 
cancer screening: Is it practi- 
cal?" at Practical Radiology 
at Whistler 2008, sponsored 
by the University of British 
Columbia, Whistler, February 
2-8. He presented "Imaging 
evaluation of the living 
related liver donor" at State 
of the Art CT & MR, spon- 
sored by the Society of Com- 
puted Body Tomography and 
Magnetic Resonance, 
Charleston, South Carolina, 
March 30-April 4. As visiting 
professor, he spoke on 
"Acute mesenteric ischemia: 
MDCT evaluation" and "CT 
colonography for colorectal 
cancer screening: current 
status" at Brown University 
Medical School, Providence, 
Rhode Island, April 7. 
Rebecca Hulett-Bowling, 
MD, assistant professor of 
radiology, as visiting profes- 
sor, spoke on "Untwisting the 
mystery of malrotation—Is it 
possible?" at the University 
of Arizona, Tucson, April 3. 
Cylen Javidan-Nejad, MD, 
assistant professor of radiol- 
ogy, spoke on "Coronary 
CTA: How to do it"; "Coro- 
nary CTA: How to read it"; 
"CT/MR of myocardial dis- 
eases"; and "Cardiac valves: 
MRI and echocardiography" 
at Non Invasive Cardiac 
Imaging Review: MDCT, 
ECHO, MRI, presented by 
Mallinckrodt Institute of 
Radiology and Somascan 
Medical Imaging, San Juan, 
Puerto Rico, February 16 
and 17. 
Richard Laforest, PhD, 
associate professor of radiol- 
ogy, presented "The three 
photon yield from e+ annihi- 
lation in biological liquids" at 
the American Physics Society 
Annual Meeting, St. Louis, 
Missouri, April 10-14. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology, spoke on "Imaging 
of brain injury in newborns" 
and "Neuro cases from the 
Mallinckrodt Institute of 
Radiology" at Cincinnati 
Children's Hospital Medical 
Center, Cincinnati, Ohio, 
March 7. 
Mark Mintun, MD, profes- 
sor of radiology, presented 
"Patterns of [nC] PIB uptake 
in non-demented subjects" at 
the Human Amyloid Imaging 
Conference, Chicago, Illinois, 
April 11. He spoke on "New 
directions in imaging— 
changing how we see AD" at 
the American Academy of 
Neurology Corporate Thera- 
peutic Update Symposium, 
Chicago, Illinois, April 15. 
Joel Perlmutter, MD, pro- 
fessor of neurology, of 
radiology, and of physical 
therapy, presented "Mecha- 
nisms of deep brain stimula- 
tion" at the Neuroscience 
Research Seminar, Univer- 
sity of Rochester, New York, 
March 6. He presented 
"Cerebral mitochondrial 
function in PD and HD" at 
Grand Rounds, University of 
Rochester, New York, March 
7. Perlmutter spoke on 
"Investigations of deep brain 
stimulation" at North Shore 
University Hospital-LIJ Med- 
ical Center, Manhasset, New 
York. He presented "PET 
investigations of dopaminer- 
gic pathways," chaired "Inte- 
grated Neuroscience 
Session: New methods in 
imaging," and spoke on 
"Starting a research career" 
at the 60* Annual Meeting of 
the American Academy of 
Neurology, Chicago, Illinois, 
April 12-19. 
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Continued from page 29 
Fred Prior, PhD, research 
associate professor of radiol- 
ogy, presented "Integration of 
images for knowledge discov- 
ery" and served as session 
chair for the National Forum 
on the Future of the Defense 
Health Informatics, Washing- 
ton, DC, March 26-28. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
spoke on "PET and PET/CT 
in gynecologic malignancies" 
and "Monitoring and predicting 
tumor response to treatment 
with PET and PET/CT" at 
Advances in Diagnostic and 
Interventional Radiology 
Symposium, sponsored by 
King Faisal Specialist 
Hospital & Research Centre, 
Riyadh, Kingdom of Saudi 
Arabia, January 8-10. He 
presented "Endocrine, RE, 
non-imaging & lymphatic, 
GI"; "PET & PET/CT coding 
& reimbursement"; and "PET 
coverage with evidence 
development (CED) & 
National Oncologic PET 
Registry (NOPR)" at the 
Society of Nuclear Medicine 
Reimbursement Seminar, 
St. Louis, Missouri, January 
18. Siegel spoke on "PET in 
gynecologic cancers" at the 
PET/CT Oncology Symposium, 
Philadelphia, Pennsylvania, 
February 9. He presented 
"PET in thoracic oncology" 
and "PET in women's 
diseases" at the Philippine 
College of Radiology 2008 
Annual Convention, Makati 
City, Manila, Philippines, 
February 21-23. 
Marilyn Siegel, MD, profes- 
sor of radiology and of 
pediatrics, presented "CT 
imaging of congenital heart 
disease," "Magnetic reso- 
nance imaging of pediatric 
bone marrow," "Advances in 
cancer imaging," and "Ultra- 
sound of pediatric spine" at 
Advances in Diagnostic and 
Interventional Radiology 
Symposium, sponsored 
by King Faisal Specialist 
Hospital & Research Centre, 
Riyadh, Kingdom of Saudi 
Arabia, January 8-10. 
She spoke on "Pediatric 
renal masses," "Neonatal 
hydronephrosis," "Renal 
cystic disease," "Pediatric 
pelvic masses," "CTA-MRA 
of pediatric liver masses," 
"Imaging acute RLQ pain in 
children," and "Pediatric 
scrotal masses" at the Philip- 
pine College of Radiology 
2008 Annual Convention, 
Makati City, Manila, Philip- 
pines, February 21-23. Siegel 
spoke on "CTA of mediastinal 
vascular anomalies" and 
"CTA of congenital heart 
disease" at Current Concepts 
in Imaging Course, sponsored 
by the Uniformed Services 
Hospital of the Health Ser- 
vices, Bethesda, Maryland, 
March 2. She presented 
"MDCT of adult congenital 
heart disease" at the 31st 
Annual Course of the Society 
of Computed Body Tomogra- 
phy and Magnetic Resonance 
Imaging, Charleston, South 
Carolina, April 4 and 5. She 
presented "Pediatric CT 
angiography," "CT angiogra- 
phy of adult mediastinal 
anomalies," and "CT angiog- 
raphy of adult congenital 
heart diseases" at Advanced 
Topics in CT Scanning: CT 
Angiography, 3D Imaging, 
Virtual Imaging Course, 
sponsored by Johns Hopkins 
University, Las Vegas, 
Nevada, April 12 and 13. 
Above: Marilyn Siegel, MD, and Barry Siegel, MD, (left) shown with other attendees at an 
evening event that was part of the symposium sponsored by King Faisal Specialist Hospital 
& Research Centre in Riyadh, Kingdom of Saudi Arabia. 
Right: Marilyn Siegel, MD, wearing a rhinestone-adorned ODOVB, the traditional outer 
garment that is mandatory attire for all women in Saudi Arabia. 
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Franz Wippold, MD, 
professor of radiology, 
presented "Head and neck 
imaging, a case-based review" 
at Saint Louis University, 
St. Louis, Missouri, April 7. 
Karen Wooley, PhD, pro- 
fessor of chemistry and of 
radiology, spoke on "Polymer 
chemistry as applied to the 
emerging field of nanotech- 
nology" at the Society of Pro- 
fessors Emeriti, Washington 
University, St. Louis, Mis- 
souri, January 14. She spoke 
on "Synthetic methods for 
the preparation of well-defined 
nanostructures, designed as 
versatile scaffolds for imag- 
ing and therapy of acute 
vascular injury, cancer, and 
other targets" at the Institute 
for Environmental Medicine, 
University of Pennsylvania 
Medical Center, Philadelphia, 
February 8. She presented 
"Polymer chemistry as 
applied to the emerging field 
of nanotechnology: with 
emphasis on devices for 
nanomedicine" at the Univer- 
sity of California, Irvine, 
March 12, and at Central 
Michigan University, Mt. 
Pleasant, April 23. Wooley 
presented "Shell crosslinked 
nanoparticles and hyper- 
branched fluoropolymers, 
each designed as complex 
nanostructures for imaging 
and therapeutic delivery in 
the diagnosis and treatment 
of pediatric brain cancers" 
at the Pediatrics Weekly 
Department Forum, Wash- 
ington University, St. Louis, 
Missouri, March 25. She 
spoke on "Amphiphilic, 
nanoscopically resolved 
crosslinked networks: 
unusual surface anti-fouling 
character, sub-surface host 
behavior, and bulk modulus 
property" at Rice University, 
Houston, Texas, March 28. 
She spoke on "Shell cross- 
linked knedel-like (SCK) 
nanoparticles and hyper- 
branched fluoropolymers 
(HBFP)" at Johns Hopkins 
University, Baltimore, Mary- 
land, April 1. Wooley pre- 
sented "RAFTpolymerization 
of functional monomers" at 
the 235"'American Chemical 
Society National Meeting, 
New Orleans, Louisiana, 
April 6. She presented "Syn- 
thesis and characterization 
of well-defined poly(acrylic 
acid)-containing homo- and 
block (co)polymers" at The 
Mitsubishi Chemical Corpo- 
ration, Tokyo, Japan, April 21. 
SYMPOSIA 
In this section ofFYI, only 
those faculty and staff who 
have Department of Radiol- 
ogy appointments are listed. 
SOCIETY OF GASTROIN- 
TESTINAL RADIOLOGISTS 
AND SOCIETY OF UROLOGY 
Abdominal Radiology 
Course 2008 
Rancho Mirage, California 
February 17-22, 2008 
Dennis Balfe, MD, "Cases 
for aces"; "ABR update"; 
"Imaging the peritoneal 
cavity: pearls and pitfalls." 
Jay Heiken, MD, "CT 
colonography: MDCT tech- 
nique"; "Diagnosing benign 
liver lesions with CT and 
MR"; Imaging the pancreas: 
neoplastic and inflammatory 
disease." 
Christine Menias, MD, 
"CT of lower abdominal 
pain"; "Acute gynecology 
conditions: US and CT." 
Cary Siegel, MD, "Solid 
renal mass and role for 
renal mass biopsy." 
CARDIAC CT 
ANGIOGRAPHY: 
A PRACTICAL APPROACH 
Sponsored by American 
Roentgen Ray Society 
Ft. Lauderdale, Florida 
February 29-March 1, 2008 
Sanjeev Bhalla, MD, 
course director. 
Sanjeev Bhalla, MD, "Case- 
based presentation: cardiac 
masses and pericardium." 
Cylen Javidan-Nejad, MD, 
"Artifacts and coronary artery 
disease," "Case-based pre- 
sentation: artifacts and CAD." 
Kevin Johnson, MD, 
"Quantification and charac- 
terization of coronary plaque." 
Marilyn Siegel, MD, "CT 
of adult congenital heart 
disease," "Case-based pre- 
sentation: CHD." 
SOCIETY OF INTERVEN- 
TIONAL RADIOLOGY 
33'* Annual Scientific 
Meeting 
Washington, DC 
March 15-20, 2008 
Michael Darcy, MD, 
"Morbidity and mortality: 
learning from our mistakes"; 
"Cases 10-12: case-based 
review: embolization"; 
"Microcatheter in peripheral." 
Colin Derdeyn, MD, 
"Endovascular stroke inter- 
vention: now and in the future." 
Craig Glaiberman, MD; 
Benjamin Jacobs; James 
Duncan, MD, PhD; 
Thomas Pilgram, PhD, 
"Simulation in training: one 
year experience using a per- 
formance to assess IR fellow 
training status." 
Nael Saad, MD; Craig 
Glaiberman, MD, "CT- 
guided percutaneous cryoab- 
lation of unresectable renal 
tumors: initial outcomes." 
Nael Saad, MD; Christine 
Menias, MD; Thomas 
Pilgram, PhD; Daniel 
Picus, MD, "Portal vein 
embolization for future liver 
remnant hypertrophy prior 
to trisegmentectomy: choice 
of embolic agent." 




ment"; "Case-based review: 
DVT and filters." 
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ASSOCIATION OF UNI- 
VERSITY RADIOLOGISTS 
56"' Annual Meeting 
Seattle, Washington 
March 25-29, 2008 
Jennifer Demertzis, MD; 
Meghan Lubner, MD; Sara 
Rohr, MD, moderators, 
"AaCR2 problem solving 1." 
Jennifer Demertzis, MD; 
Meghan Lubner, MD; Sara 
Rohr, MD, moderators, 
"A'CR2 problem solving 2: 
the role of informatics in 
optimizing resident education." 
Bennett Greenspan, MD 
moderator, "Society of 
Nuclear Medicine Session: 
Radiation safety radiophar- 
macy and regulatory issues— 
an update for senior radiology 
residents." 
Christine Peterson, MD, 
moderator; Faculty: 
Jonathan Baker, MD; 
Dennis Balfe, MD; Sanjeev 
Bhalla, MD; Jennifer 
Demertzis, MD; Travis 
Hillen, MD; Meghan 
Lubner, MD; Sara Rohr, 
MD; Jason Stephenson, 
MD, "Philips Vydareny imag- 
ing interpretation competition 
—preliminary (presented by 
Mallinckrodt Institute of 
Radiology)." 
Joshua Shimony, MD, 
PhD, "Informatics and func- 
tional brain connectivity." 
AMERICAN ROENTGEN 
RAY SOCIETY 
108'" Annual Meeting 
Washington, DC 
April 13-18, 2008 
Sanjeev Bhalla, MD, "CT 
evaluation of pulmonary 
embolic disease"; "CT of 
acute lung and pleural: 
traumatic and nontraumatic 
findings"; "Cardiovascular 
imaging: CXR findings of 
cardiac disease"; "Congenital 
conditions." 
Jay Heiken, MD, "The 
PREDICT study: a randomized 
double-blind comparison of 
contrast-induced nephropa- 
thy after a low- or iso-osmolar 
contrast agent in high-risk 
patients." 
Cylen Javidan-Nejad, MD, 
"Cardiovascular imaging: 
coronary arteries." 
Meghan Lubner, MD; 
Sanjeev Bhalla, MD; 
Cylen Javidan-Nejad, MD; 
Christine Menias, MD, 
"Atypical imaging features of 
fibrosing mediastinitis." 
Meghan Lubner, MD; 
Christine Menias, MD; 
Christine Peterson, MD; 
Sanjeev Bhalla, MD, 
"Atypical imaging features of 
gastrointestinal (GI) stromal 
tumors." 
Prakash Masand, MD; 
Marilyn Siegel, MD, 
"Noninvasive evaluation of 
post surgical cardiovascular 
conduits in the pediatric age 
group using multidetector 
imaging." 
Prakash Masand, MD; 
Sushilkumar Sonavane, 
MD; Marilyn Siegel, MD, 
"CT angiography of abdomi- 
nal coarciation in children." 
Christine Menias, MD, "CT 
of acute intestinal ischemia 




imaging spectrum"; "Border- 
line ovarian tumors: of 
borderline significance?" 
Marilyn Siegel, MD, 
"Imaging of pediatric abdom- 
inal emergencies." 
Pamela Woodard, MD, 
Keynote Lecture—"Cardiac 
CT: the future." 
SOCIETY FOR PEDIATRIC 
RADIOLOGY 
51s' Annual Meeting and 
Postgraduate Course 
Scottsdale, Arizona 
May 6-10, 2008 
Steven Don, MD; Bruce 
Whiting, PhD; Parinaz 
Massoumzadeh, PhD, 
"Evaluation of quality assur- 
ance control phantom 
for digital neonatal chest 
projection imaging." 
—Caffey Award for Best 
Basic Science Paper 
William McAlister, MD, 
"Bisphosphonate-induced 
osteopetrosis: novel bone 
modeling defects, osteoscle- 
rosis fractures, and metaphy- 
seal osteopenia after drug 
exposure ceases"; "Physeal 
closure from chronic vitamin 
A intoxication"; "Osteopro- 
tegerin deficiency (Juvenile 
Paget's disease): responses 
to oral and IV bisphospho- 
nates in 3 children"; "Molecu- 
lar exclusion of mutations in 
EXT; and EXT2 as the cause 
of metachondromatosis." 
Prakash Masand, MD; 
Marilyn Siegel, MD, "CT 
angiography of pulmonary 
atresia, pre and post repair"; 
"Patterns of delayed myocar- 
dial enhancement on cardiac 
MRI in pediatric patients 
with myocarditis." 
Prakash Masand, MD; 
Rebecca Hulett-Browning, 
MD, "Multidetector CT 
angiography in the evalua- 
tion of congenital thoracic 
aortic anomalies in the 
pediatric age group." 
Marilyn Siegel, MD, 
"Cardiac CTA: congenital 
heart disease." 
Sushilkumar Sonavane, 
MD; Madelyn Stazzone, 
MD, "Prenatal fetal MRI 
imaging in genitourinary 
abnormalities." 
Madelyn Stazzone, MD, 
"Osteomyelitis of the pubic 
symphisis: MR findings and 
pitfalls in diagnosis"; "2D- 
flash sequences: Should they 
be part of the standard 
Oprotocol for fetal MRI?" 
Editor's Note: In the listing of MIR's 2007 RSNA Grant 
Recipients (page 6 in the Winter 2007/2008 issue of 
Focal Spot), the Toshiba Research Scholar Grant 
should have read: Jeffrey Lin, MD, PhD, "Noninvasive 
characterization of NFkB activation in non-alcoholic 
fatty liver disease." 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Imaging Sciences Retreat 
Pathways to Discovery C 
**• \ t 
Below: David Piwnico-Worms, PhD, professor of radiology and 
director of the Washington University Molecular Imaging Center. 
IHOTSr-; j 




Imaging in the 
Bmph 
'"'"■'■ ' UII   al Industry 
Above: As part 
Evelhoch, PhD, director ot Imaging Sciences Imaging at Amgen, Inc., discussed 
"Imaging in the biopharmoceutical industry." 
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